CVS Health company headlines, earnings, strategy, leadership, and market-moving business updates.
Market data may be delayed. For informational purposes only. Not investment advice.
A recent commentary tied behavioral health to cardiovascular outcomes, underscoring how depression, anxiety and chronic stress may affect risk and recovery in patients.
THE APEX TIMES
THE APEX TIMES
On its Q2 2026 conference call transcript published by Yahoo Finance, CVS Health said adjusted earnings per share jumped 42.5%, attributing the increase to margin recovery across operating segments.
THE APEX TIMES
AbbVie is viewed by the market as a specialty-drug growth story, while CVS Health is priced more like a mature healthcare services operator, even as it manages tens of millions of covered lives.
THE APEX TIMES
The health insurer and pharmacy retailer said it was recognized for building organization-wide AI literacy and colleague confidence through its AI Learning Academy.
THE APEX TIMES
A Wall Street fair-value target for CVS Health has risen slightly, from about $111.92 to $114.88, reflecting a more constructive tone from analysts according to a report published by Yahoo Finance.
THE APEX TIMES
Management said the latest quarter reinforced momentum in Aetna and its retail business, lifting expectations for 2026, while warning that proposed 340B-related changes and softer Caremark membership could weigh on later results.
THE APEX TIMES
A new CVS Health Company Newsroom piece highlights wildfire smoke, extreme heat and Cyclospora as summertime risks, and points to how its retail pharmacists and health services can help people respond when conditions shift fast.
THE APEX TIMES
The health-care retailer and pharmacy benefit operator reported second-quarter results that topped expectations, citing growth across its operating segments and prompting an upward revision to its full-year guidance for adjusted earnings per share and operating performance.
THE APEX TIMES
CVS Health reported second-quarter results that beat Wall Street expectations and raised its full-year outlook. Still, the stock fell, underscoring how investors can focus on what is not fully captured in guidance.
